2023 Alaska Rheumatology Alliance Meeting

April 7, 2023 to April 8, 2023

Thank you for joining us at the Alaska Rheumatology Alliance Meeting!

Please select “Register/Take Course” to complete the following:

  • Pre-Test
  • Post-Test
  • Program Evaluation

Upon completion, you will receive your accreditation certificate. 

The pre-test will close on Friday, April 7, 2023 at 2:00 PM AKDT.
The post-program activities will become available on Saturday, April 8, 2023 at 2:30 PM AKDT.

Target Audience

This initiative is designed for rheumatology healthcare professionals who treat rheumatic diseases.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Review data on the prevalence of rheumatic diseases.
  • Describe the progressive nature and detrimental effects of untreated rheumatic diseases.
  • Discuss updates in diagnosis, classification and treatment guidelines and demonstrate strategies to incorporate these guidelines into practice.
  • Analyze recently approved and emerging treatment options, including a review of their safety and efficacy through analysis of how new agents are improving patient care.
  • Identify and analyze any “hot topics” in specific areas of rheumatic disease.
Course summary
Available credit: 
  • 4.25 AMA PRA Category 1 Credit™
  • 4.25 AMA PRA Category 1 Credit™ (Non- MD)
Course opens: 
04/05/2023
Course expires: 
04/07/2024
Event starts: 
04/07/2023 - 4:00pm EDT
Event ends: 
04/08/2023 - 7:00pm EDT
Add to calendar: 
Rating: 
0

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and ARTHROS. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

 

Credit Designation:

Purdue University College of Pharmacy designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosure Statement/Conflict of Interest Policy

To ensure compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Purdue University requires that all individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest identified are thoroughly assessed by Purdue University to ensure fair balance, scientific rigor, and accepted patient care recommendations of the educational activity.

All relevant conflicts of interest have been mitigated prior to the start of the activity.

None of the planners, reviewers, ARTHROS staff, and Purdue University College of Pharmacy staff have relevant financial relationship(s) with ineligible companies to disclose unless listed below.

Each faculty member will disclose any relationship at the beginning of each presentation.

 

This activity is supported by educational grants from AbbVie and Janssen Pharmaceuticals.

Available Credit

  • 4.25 AMA PRA Category 1 Credit™
  • 4.25 AMA PRA Category 1 Credit™ (Non- MD)
Please login or register to take this course.